Evidence map›Paper›PMID 23858425›Full record

ArticlePediatrics2013

Results from the New Jersey statewide critical congenital heart defects screening program.

Lorraine F Garg, Kim Van Naarden Braun, Mary M Knapp, Terry M Anderson, Robert I Koppel, Daniel Hirsch, Leslie M Beres, Joseph Sweatlock, Richard S Olney, Jill Glidewell and 2 more

Abstract read
In one paragraph

Article in Pediatrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Evaluation of critical congenital heart defects screening using pulse oximetry in the neonatal intensive care unit.Journal of perinatology : official journal of the California Perinatal Association · 2017
    Article
  13. Article
  14. Article
  15. Pulse oximetry screening for critical congenital heart disease in the neonatal intensive care unit.Journal of perinatology : official journal of the California Perinatal Association · 2016
    Article
  16. Observational
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Lorraine F GargDivision of Family Health Services, New Jersey Department of Health, PO Box 364, Trenton, NJ 08625-0364, USA. lori.garg@doh.state.nj.us
Kim Van Naarden Braun
Mary M Knapp
Terry M Anderson
Robert I Koppel
Daniel Hirsch
Leslie M Beres
Joseph Sweatlock
Richard S Olney
Jill Glidewell
Cynthia F Hinton
Alex R Kemper
New Jersey Department of Health · USCenters for Disease Control and Prevention · USChildren's Hospital of Philadelphia · USCohen Children's Medical Center · USDuke University · USJohnson University · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

BACKGROUND AND

objectiveNew Jersey was the first state to implement legislatively mandated newborn pulse oximetry screening (POxS) in all licensed birthing facilities to detect critical congenital heart defects (CCHDs). The objective of this report was to evaluate implementation of New Jersey's statewide POxS mandate.

methodsA 2-pronged approach was used to collect data on infants screened in all New Jersey birthing facilities from August 31, 2011, through May 31, 2012. Aggregate screening results were submitted by each birthing facility. Data on failed screens and clinical characteristics of those newborns were reported to the New Jersey Birth Defects Registry (NJBDR). Three indicators were used to distinguish the added value of mandated POxS from standard clinical care: prenatal congenital heart defect diagnosis, cardiology consultation or echocardiogram indicated or performed before PoxS, or clinical findings at the time of POxS warranting a pulse oximetry measurement.

resultsOf 75,324 live births in licensed New Jersey birthing facilities, 73,320 were eligible for screening, of which 99% were screened. Forty-nine infants with failed POxS were reported to the NJBDR, 30 of whom had diagnostic evaluations solely attributable to the mandated screening. Three of the 30 infants had previously unsuspected CCHDs and 17 had other diagnoses or non-CCHD echocardiogram findings.

conclusionsIn the first 9 months after implementation, New Jersey achieved a high statewide screening rate and established surveillance mechanisms to evaluate the unique contribution of POxS. The screening mandate identified 3 infants with previously unsuspected CCHDs that otherwise might have resulted in significant morbidity and mortality and also identified other significant secondary targets such as sepsis and pneumonia.

Indexed as

OximetryCardiologyCross-Sectional StudiesEchocardiographyFemaleHealth Plan ImplementationHeart Defects, CongenitalHumansInfant, NewbornMaleNeonatal ScreeningNew JerseyReferral and ConsultationRegistriescongenital heart disease/defectsnewborn screeningoximetrysurveillance and monitoring

Identifiers

PMID23858425
PMCPMC4471476
OpenAlexW2076660873

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.